Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

The interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r) and the NS5A inhibitor ombitasvir (also known as ABT-267) plus the nonnucleoside polymerase inhibitor dasabuvir (also known as ABT-333) and ribavirin has shown efficacy against the hepatitis C virus (HCV) in...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Jordan J. Feld, Kris V. Kowdley, Eoin Coakley, Samuel H. Sigal, David R. Nelson, Dorothy H. Crawford, Ola Weiland, Humberto Aguilar, Junyuan Xiong, Edward Tam, Barbara DaSilva-Tillmann, Lois Larsen, Thomas Podsadecki, Barry Bernstein
Médium: Artigo
Jazyk:angličtina
Vydáno: 2014
On-line přístup:https://doi.org/10.1056/nejmoa1315722
https://www.nejm.org/doi/pdf/10.1056/NEJMoa1315722?articleTools=true
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.1056/nejmoa1315722
https://www.nejm.org/doi/pdf/10.1056/NEJMoa1315722?articleTools=true

Podobné jednotky